Navigation Links
AbbVie to Present at Cowen 35th Annual Health Care Conference
Date:2/25/2015

NORTH CHICAGO, Ill., Feb. 25, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Cowen 35th Annual Health Care Conference on Wednesday, March 4, 2015. Bill Chase, executive vice president and chief financial officer, will make a presentation on the company and participate in a question and answer session at 9 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations Web site at www.abbvieinvestor.com.  An archived edition of the session will be available later that day.

About AbbVie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs more than 26,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.


'/>"/>
SOURCE AbbVie
Copyright©2015 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Revised GAAP earnings guidance for AbbVie Inc for the Financial Year ending December 31, 2014 and Third Quarter ending September 30, 2014; Confirms Adjusted Earnings Guidance
2. AbbVie And Calico Announce A Novel Collaboration To Accelerate The Discovery, Development And Commercialization Of New Therapies
3. AbbVie Announces Inaugural Week of Possibilities Volunteer Program to Support Six Schools in North Chicago, Ill., and Worcester, Mass.
4. AbbVie and North Chicago Public Schools Announce $350,000 Grant to Advance Math Education
5. AbbVie to Present at Jefferies 2013 Healthcare Conference
6. AbbVie to Present at Credit Suisse 2013 Healthcare Conference
7. AbbVie to Present at Morgan Stanley Global Healthcare Conference
8. Vote to Help Award a $21,000 AbbVie CF Scholarship to Two Inspirational Students with Cystic Fibrosis Pursuing their Goals of Higher Education
9. AbbVie Presents Results from Phase I Study of Investigational Oncology Compound ABT-199 at American Society of Clinical Oncology Annual Meeting
10. StockCall Scrutinizes Pfizer, Merck & Co., Johnson & Johnson, and AbbVie
11. GenomeDxs Decipher Shows Broad Applicability in Advancing Prostate Cancer Care in Data Presented at 2015 ASCO Genitourinary Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2019)... ... 2019 , ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived ... for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The ... This IND is the first of several planned clinical trials which will enable ...
(Date:6/11/2019)... MONTREAL (PRWEB) , ... June 10, 2019 , ... ... growth of its distribution network with the appointment of Biofeedback Tech Ltd ... physiological monitoring systems are an essential part of many therapeutic treatments and clinical ...
(Date:6/11/2019)... ... June 10, 2019 , ... ... add 80 of its scientific journals to DeepDyve’s rental service for peer-reviewed journals. ... continually expanding library of more than 20 million articles, sourced from more than ...
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative Medicine ... (PSC) , has announced that their GMP facility for cell production is now ... manufacturing. This is an important milestone for VetStem as it expands into ...
Breaking Biology Technology:
(Date:6/6/2019)... ... June 05, 2019 , ... Ziegler, a specialty investment bank, ... Bio-Medical Laboratories (PBM) on its recent acquisition by PathGroup. , Headquartered in ... to more than one dozen hospitals and surgery centers in the Dallas-Fort Worth ...
(Date:6/4/2019)... TORONTO (PRWEB) , ... June 04, 2019 , ... ... automate the search for salient features of seizure risk signals, usually based on ... neurologist-driven EEG interpretation remains the only acceptable diagnostic methodology due to the complexity ...
(Date:5/31/2019)... ... May 29, 2019 , ... FileWave, the ... mobile, announces the launch of version 13.1. The new version extends FileWave’s mobile ... and supports Apple’s spring release functionality. Version 13.1 builds on FileWave’s version 13 ...
Breaking Biology News(10 mins):